Emerging anti-cancer molecular mechanisms of aminobisphosphonatesMichele Caraglia, Alfredo Budillon|Endocrine Related Cancer|2006Cited by 131
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple MyelomaMaria Teresa Di Martino, Michele Caraglia|PLoS ONE|2014Cited by 115
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysFrancesca Bruzzese, Alfredo Budillon, Biagio Pucci et al.|Cell Death and Disease|2013Cited by 57
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatmentMayra Rachele Zarone, Michele Caraglia|Scientific Reports|2017Cited by 49
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple MyelomaGabriella Misso, Michele Caraglia|Molecular Therapy — Nucleic Acids|2019Cited by 41